Ruxia Ding

819 total citations
7 papers, 158 citations indexed

About

Ruxia Ding is a scholar working on Infectious Diseases, Animal Science and Zoology and Genetics. According to data from OpenAlex, Ruxia Ding has authored 7 papers receiving a total of 158 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 5 papers in Animal Science and Zoology and 2 papers in Genetics. Recurrent topics in Ruxia Ding's work include SARS-CoV-2 and COVID-19 Research (7 papers), Animal Virus Infections Studies (5 papers) and COVID-19 Clinical Research Studies (3 papers). Ruxia Ding is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), Animal Virus Infections Studies (5 papers) and COVID-19 Clinical Research Studies (3 papers). Ruxia Ding collaborates with scholars based in China, United States and Czechia. Ruxia Ding's co-authors include Jianhui Nie, Youchun Wang, Weijin Huang, Qianqian Li, Jiajing Wu, Shuo Liu, Haixin Wang, Yue Zhang, Yuanling Yu and Xuan Zou and has published in prestigious journals such as Frontiers in Immunology, Signal Transduction and Targeted Therapy and Archives of Virology.

In The Last Decade

Ruxia Ding

7 papers receiving 154 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruxia Ding China 5 140 31 21 19 19 7 158
Xiangyang Ge China 9 129 0.9× 54 1.7× 23 1.1× 20 1.1× 20 1.1× 22 166
Jianhui Nie China 2 224 1.6× 64 2.1× 23 1.1× 14 0.7× 16 0.8× 3 256
Martin Mayora Neto United Kingdom 9 155 1.1× 21 0.7× 28 1.3× 8 0.4× 29 1.5× 19 186
Shan-Lu Liu United States 3 160 1.1× 39 1.3× 29 1.4× 8 0.4× 17 0.9× 3 180
Esther A. Bondzie United States 6 88 0.6× 19 0.6× 20 1.0× 9 0.5× 35 1.8× 11 125
Rachael E. Whaley United States 2 198 1.4× 56 1.8× 24 1.1× 36 1.9× 44 2.3× 2 214
Sebastian Einhauser Germany 8 121 0.9× 31 1.0× 19 0.9× 6 0.3× 21 1.1× 14 146
Bradley Whitener United States 5 81 0.6× 26 0.8× 19 0.9× 25 1.3× 27 1.4× 5 106
Shitong Qiao China 4 93 0.7× 28 0.9× 22 1.0× 18 0.9× 15 0.8× 8 103
Cas LeMaster United States 6 181 1.3× 25 0.8× 33 1.6× 9 0.5× 28 1.5× 11 202

Countries citing papers authored by Ruxia Ding

Since Specialization
Citations

This map shows the geographic impact of Ruxia Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruxia Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruxia Ding more than expected).

Fields of papers citing papers by Ruxia Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruxia Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruxia Ding. The network helps show where Ruxia Ding may publish in the future.

Co-authorship network of co-authors of Ruxia Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Ruxia Ding. A scholar is included among the top collaborators of Ruxia Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruxia Ding. Ruxia Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Wang, Haixin, Li Zhang, Ziteng Liang, et al.. (2022). Infectivity and antigenicity of pseudoviruses with high-frequency mutations of SARS-CoV-2 identified in Portugal. Archives of Virology. 167(2). 459–470. 3 indexed citations
2.
Wu, Jiajing, Jianhui Nie, Li Zhang, et al.. (2022). The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain. Signal Transduction and Targeted Therapy. 7(1). 18–18. 13 indexed citations
3.
Wu, Jiajing, Li Zhang, Yue Zhang, et al.. (2021). The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom. Frontiers in Immunology. 12. 687869–687869. 13 indexed citations
4.
Luo, Huanle, Tingting Jia, Jiamin Chen, et al.. (2021). The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients. Frontiers in Immunology. 12. 632814–632814. 61 indexed citations
5.
Zhang, Li, Qianqian Li, Bo Wang, et al.. (2021). Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization. Communications Biology. 4(1). 1196–1196. 43 indexed citations
6.
Zhang, Yue, Li Zhang, Jiajing Wu, et al.. (2021). A second functional furin site in the SARS-CoV-2 spike protein. Emerging Microbes & Infections. 11(1). 182–194. 23 indexed citations
7.
Ding, Ruxia, Haixin Wang, Yi Yang, et al.. (2020). Cross-Neutralizing Activity of Monoclonal Antibodies Against N501Y Mutant Strain of SARS-CoV-2. 9(4). 41–45. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026